Literature DB >> 15661232

Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells.

Wenxuan Yang1, Samuel E Toffa, Jonathan W G Lohn, Alexander M Seifalian, Marc C Winslet.   

Abstract

OBJECTIVES: The antioxidant status of cancer cells is an important factor in tumor invasion and metastases. This study investigated whether metastatic cancer cells derive beneficial antioxidant protection from ascitic fluid and are rendered resistant to oxidative stress in the form of a chemically generated free radical insult.
METHODS: Human gastric carcinoma (KATO-III) and ovarian adenocarcinoma (SKOV-3) cell lines were cultured and incubated for 24 h with (1) M199 medium; (2) M199 + 20% fetal calf serum (FCS); (3) malignant ascites. All cells were exposed to a hydroxyl radical-generating system for 1 h. Cellular lipid peroxidation was assessed by measuring malondialdehyde (MDA) in cell suspensions. Glutathione (GSH) levels in cell pellet were measured in SKOV-3 cells after 0, 24, 48, and 72 h of incubation with buthionine sulphoximine (BSO). CD44 gene expression of cancer cells was analyzed by Northern blotting.
RESULTS: The results showed that the cancer cells were rendered resistant to oxidative stress and with upregulated CD44 gene expression by components of malignant ascites.
CONCLUSIONS: These findings suggest that malignant ascites increases the antioxidant ability of cancer cells and the potential of adhesion and invasion. Thus, determination of the nature of these putative tumor-protective components of ascites may provide targets for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661232     DOI: 10.1016/j.ygyno.2004.10.016

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft.

Authors:  Marie-France Penet; Arvind P Pathak; Venu Raman; Paloma Ballesteros; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2009-10-27       Impact factor: 12.701

2.  PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.

Authors:  C Papadaki; M Sfakianaki; E Lagoudaki; G Giagkas; G Ioannidis; M Trypaki; E Tsakalaki; A Voutsina; A Koutsopoulos; D Mavroudis; V Georgoulias; J Souglakos
Journal:  Br J Cancer       Date:  2014-09-18       Impact factor: 7.640

Review 3.  Insights into the Role of Oxidative Stress in Ovarian Cancer.

Authors:  Dan-Ni Ding; Liang-Zhen Xie; Ying Shen; Jia Li; Ying Guo; Yang Fu; Fang-Yuan Liu; Feng-Juan Han
Journal:  Oxid Med Cell Longev       Date:  2021-10-07       Impact factor: 6.543

4.  Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.

Authors:  Hee-Sung Ahn; Jung Yoon Ho; Jiyoung Yu; Jeonghun Yeom; Sanha Lee; Soo Young Hur; Yuyeon Jung; Kyunggon Kim; Youn Jin Choi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.